Serum IL-33 level and IL-33, IL1RL1 gene polymorphisms in asthma and multiple sclerosis patients.

Conclusion: Our findings demonstrated that asthma and MS patients had a higher level of IL-33, which IL-33 receptor genetic polymorphism was associated with MS. Further studies in a larger multicenter setting are needed to explore the value of this marker as a risk stratification biomarker.
PMID: 30950351 [PubMed - as supplied by publisher]

Source: Current Molecular Medicine - April 4, 2019 Category: Molecular Biology Authors: Ahmadi M, Fathi F, Fouladi S, Alsahebfosul F, Manian M, Eskandari N Tags: Curr Mol Med Source Type: research